SecBot SecBot
PRESS-RELEASE ·Filed Mar 24, 2026

BMGL

Basel Medical Group Ltd
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

Traders should monitor for the upcoming release of actual 2025 financial results in the Form 20-F filing, which may provide material data. For now, the news removes regulatory overhang but does not signal operational improvement.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
BMGL ▼ -3.58% at T+60d
NEUTRAL call -3.58% · α vs SPY -17.90% · entry $0.6400 → $0.6171
Entry = T+0 close
Mar 24, 2026
via day close
T+1d
-5.31%
call -5.31% · α -5.88%
$0.6060
settled 7mo ago
T+5d
-7.81%
call -7.81% · α -7.39%
$0.5900
settled 7mo ago
T+20d
-3.13%
call -3.13% · α -12.03%
$0.6200
settled 6mo ago
T+60d
-3.58%
call -3.58% · α -17.90%
$0.6171
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Basel Medical Group Ltd announced it has resolved its Nasdaq filing deficiency after submitting its amended 2025 annual report on Form 20-F. The company is now in compliance with Nasdaq's periodic filing requirements, lifting a prior delisting concern.

Key Facts

  • Nasdaq has confirmed Basel Medical Group Ltd is now in compliance with Listing Rule 5250(c)(1) after filing its amended 2025 Form 20-F.
  • The deficiency related solely to late filing of periodic reports; no financial restatement or material adverse finding was disclosed.
  • No financial results, revenue, earnings, or guidance were included in the press release.
  • Company remains listed on Nasdaq with market cap of $13M.

Financial Impact

No direct financial impact disclosed; resolution avoids potential delisting.

compliance statuslisting risk

Risk Factors

  • Underlying financial performance for 2025 remains unknown and may be weak given prior filing delays.
  • Market cap remains very small ($13M), indicating high illiquidity and volatility risk.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3261028
11 reports for BMGL
Performance horizon
50% Hit rate @ T+1 2 of 4 directional calls Went positive at some point 3 of 4 best @ T+20▲ +2.45%Aug 10, 2026
Filters
Rows
Reports for BMGL — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
6-K
BEARISH ★ 7/10
$3.85 $3.85· 0.00%▼ −1.08%$4.55 (−18.18%)
Oct 9, 2026
17d ago
6-K
BEARISH ★ 5/10
$3.75 $3.71▲ +1.07%▲ +1.01%$4.55 (−21.33%)
Oct 8, 2026
18d ago
424B4
BEARISH ★ 7/10
$3.75 $3.71▲ +1.07%▲ +1.01%$4.55 (−21.33%)
Sep 30, 2026
26d ago
EFFECT
NEUTRAL ★ 4/10
$3.12 $3.02▼ −3.21%▼ −3.38%$4.55 (+45.83%)
Sep 2, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$4.94 $4.78▼ −3.24%▼ −4.29%$4.55 (−7.89%)
Aug 10, 2026
11w ago
6-K
BEARISH ★ 5/10
$4.90 $4.99▼ −1.84%▼ −2.16%$4.55 (+7.14%)
Jul 10, 2026
15w ago
6-K
NEUTRAL ★ 4/10
$6.61 $6.14▼ −7.04%▼ −6.27%$4.55 (−31.11%)
Jun 10, 2026
19w ago
6-K
NEUTRAL ★ 3/10
$0.5869 $0.5783▼ −1.47%▼ −3.17%$4.55 (+675.26%)
Jun 5, 2026
20w ago
6-K
NEUTRAL ★ 3/10
$0.5445 $0.5946▲ +9.20%▲ +8.97%$4.55 (+735.63%)
Mar 30, 2026
30w ago
6-K
NEUTRAL ★ 3/10
$6.60 $7.08▲ +7.27%▲ +4.37%$4.55 (−31.06%)
Showing 10 of 11

US Market Status

Market Closed — Opens Tue (15h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 24, 2026